Linden Thomas Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.39M Buy
13,907
+104
+0.8% +$61.8K 0.75% 14
2026
Q2
$6.92M Buy
13,803
+128
+0.9% +$61.4K 0.56% 26
2026
Q1
$6.72M Buy
13,675
+311
+2% +$169K 0.65% 13
2025
Q4
$7.74M Buy
13,364
+161
+1% +$91K 0.78% 13
2025
Q3
$6.4M Buy
13,203
+565
+4% +$263K 0.65% 19
2025
Q2
$5.12M Buy
12,638
+7,241
+134% +$3.03M 0.56% 31
2025
Q1
$2.69M Buy
5,397
+651
+14% +$353K 0.35% 76
2024
Q4
$2.47M Buy
4,746
+569
+14% +$313K 0.31% 86
2024
Q3
$2.58M Buy
4,177
+701
+20% +$415K 0.35% 70
2024
Q2
$1.92M Buy
3,476
+593
+21% +$340K 0.3% 101
2024
Q1
$1.68M Buy
2,883
+1,099
+62% +$617K 0.27% 133
2023
Q4
$947K Buy
1,784
+238
+15% +$115K 0.18% 239
2023
Q3
$783K Buy
1,546
+125
+9% +$66.6K 0.17% 254
2023
Q2
$741K Buy
1,421
+225
+19% +$121K 0.16% 251
2023
Q1
$689K Buy
1,196
+382
+47% +$215K 0.17% 235
2022
Q4
$448K Buy
+814
New +$431K 0.13% 262

Other funds holding TMO

Linden Thomas Advisory Services's TMO Position: Q3 2026 in Review

Linden Thomas Advisory Services increased its Thermo Fisher Scientific (TMO) stake by 0.75% in Q3 2026, buying an estimated $61.8K and bringing the position to 13,907 shares worth $9.39M. The position accounts for 0.75% of the portfolio, ranked #14.

Linden Thomas Advisory Services first reported a position in TMO in Q4 2022 and has held it in 16 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Linden Thomas Advisory Services held 13,907 shares of Thermo Fisher Scientific worth $9.39M as of Q3 2026.
  • Linden Thomas Advisory Services bought 104 Thermo Fisher Scientific shares in Q3 2026, an estimated $61.8K.
  • Thermo Fisher Scientific made up 0.75% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #14 holding.
  • Linden Thomas Advisory Services first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 16 quarters since.
  • 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.